Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
High-dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric High-risk Brain Tumors
Phase 2
- Conditions
- Brain Tumor
- Interventions
- Procedure: high-dose chemotherapy and autologous stem cell rescue
- First Posted Date
- 2008-11-26
- Last Posted Date
- 2020-03-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00798811
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Phase 3
Completed
- Conditions
- Thyroid Cancer
- Interventions
- Procedure: Prophylactic central lymph node dissection
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2016-04-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 258
- Registration Number
- NCT00795782
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma
Phase 2
Completed
- Conditions
- Neuroblastoma
- Interventions
- Radiation: Total body irradiation
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00793845
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Procedure: Conservative strategyProcedure: Aggressive strategy
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2013-02-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 258
- Registration Number
- NCT00794014
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation
Phase 2
Completed
- Conditions
- Neuroblastoma
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00793351
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation
Not Applicable
Completed
- Conditions
- Kidney TransplantationLiving Donors
- Interventions
- First Posted Date
- 2008-10-22
- Last Posted Date
- 2011-04-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 131
- Registration Number
- NCT00777933
- Locations
- 🇰🇷
Transplantation Center, Samsung Medical Center, Seoul, Korea, Republic of
A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2008-10-22
- Last Posted Date
- 2008-10-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 93
- Registration Number
- NCT00777452
- Locations
- 🇰🇷
Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 37
- Registration Number
- NCT00767754
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 46
- Registration Number
- NCT00767871
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque
Not Applicable
- Conditions
- Acute Coronary Syndrome
- Interventions
- Drug: Intensive lipid lowering plus Omega3-fatty acidDrug: Moderate lipid lowering plus Omega3-fatty acidDrug: Intensive lipid lowering plus placeboDrug: Moderate lipid lowering plus placebo
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2008-09-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT00760786
- Locations
- 🇰🇷
Cardiac and Vascular Center; Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath